Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fletcher

Showing results (1231-1240 of 1,501) with videos related to

Pageof 151
Sort By:
BMC Cancer|July 16, 2016
No preclinical rationale for IGF1R directed therapy in chondrosarcoma of boneElisabeth F P Peterse, Arjen H G Cleven, Yvonne De Jong, et al.
Current Protocols in Human Genetics|July 8, 2011
Reporting of diagnostic cytogenetic resultsAzra H Ligon, Cynthia C Morton, Frederick R Bieber, et al.
Medicine and Science in Sports and Exercise|July 23, 1999
Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infectionF M Perna, A LaPerriere, N Klimas, et al.
The American Journal of Pathology|August 10, 2000
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumorsB Lawrence, A Perez-Atayde, M K Hibbard, et al.
Urologic Oncology|December 14, 2020
Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patientsMaxine Sun, Maya Marchese, David F Friedlander, et al.
British Journal of Cancer|April 26, 2014
Multipoint targeting of the PI3K/mTOR pathway in mesotheliomaS Zhou, L Liu, H Li, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
BJU International|January 28, 2025
Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillanceMaximilian Pallauf, Michael Rezaee, Roy Elias, et al.
Kidney International|April 29, 2023
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trialsHiddo J L Heerspink, Niels Jongs, Brendon L Neuen, et al.
The American Journal of Pathology|April 28, 2004
Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12)Anna Dahlén, Christopher D M Fletcher, Fredrik Mertens, et al.
Pageof 151

Showing results (1231-1240 of 1,501) with videos related to

Sort By:
Pageof 151
BMC Cancer|July 16, 2016
No preclinical rationale for IGF1R directed therapy in chondrosarcoma of boneElisabeth F P Peterse, Arjen H G Cleven, Yvonne De Jong, et al.
Current Protocols in Human Genetics|July 8, 2011
Reporting of diagnostic cytogenetic resultsAzra H Ligon, Cynthia C Morton, Frederick R Bieber, et al.
Medicine and Science in Sports and Exercise|July 23, 1999
Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infectionF M Perna, A LaPerriere, N Klimas, et al.
The American Journal of Pathology|August 10, 2000
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumorsB Lawrence, A Perez-Atayde, M K Hibbard, et al.
Urologic Oncology|December 14, 2020
Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patientsMaxine Sun, Maya Marchese, David F Friedlander, et al.
British Journal of Cancer|April 26, 2014
Multipoint targeting of the PI3K/mTOR pathway in mesotheliomaS Zhou, L Liu, H Li, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
BJU International|January 28, 2025
Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillanceMaximilian Pallauf, Michael Rezaee, Roy Elias, et al.
Kidney International|April 29, 2023
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trialsHiddo J L Heerspink, Niels Jongs, Brendon L Neuen, et al.
The American Journal of Pathology|April 28, 2004
Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12)Anna Dahlén, Christopher D M Fletcher, Fredrik Mertens, et al.
Pageof 151